Author | Cohort (n) | HIV transmission group (%) | Pre-HAART | HAART era | |||
---|---|---|---|---|---|---|---|
SIR | 95% CI | SIR | 95% CI | ||||
SIR, standardised incidence ratio; HAART, highly active antiretroviral treatment; IVDU, intravenous drug user. | |||||||
Parker24 | 26181 | 6.5 | 4.9 to 8.9 | ||||
Grulich8 | 3616 | 3.8 | 1.4 to 8.3 | ||||
Frish23 | 302834 | All | 4.5 | 4.2 to 4.8 | |||
Men | 84 | 4.3 | 4 to 4.6 | ||||
Women | 16 | 7.1 | 5.9 to 8.6 | ||||
Homosexual | 47 | 3.7 | 3.3 to 4.1 | ||||
IVDU | 35 | 6.8 | 6.1 to 7.6 | ||||
Heterosexual | 11 | 4.2 | 3.3 to 4.1 | ||||
Unknown | 7 | ||||||
Dal Maso26 | 60421 | All | 2.4 | 1.5 to 3.7 | |||
Men | 78 | 2.2 | 1.3 to 3.4 | ||||
Women | 22 | 8.7 | 1.6 to 25.9 | ||||
IVDU | 62 | 9.4 | 4.6 to 16.8 | ||||
Others | 38 | 1.4 | 0.7 to 2.5 | ||||
Herida21 | 57428 | Men | 75 | 1.13 | 0.71 to 1.72 | 2.12 | 1.67 to 2.65 |
Women | 25 | 1.08 | 0.01 to 5.98 | 6.59 | 3.4 to 11.5 | ||
Homosexual | 57 | 0.92 | 0.42 to 1.75 | 1.78 | 1.22 to 2.49 | ||
IVDU | 16 | 3.16 | 1.15 to 6.87 | 4.70 | 2.83 to 7.34 | ||
Heterosexual | 22 | 0.99 | 0.27 to 2.53 | 1.92 | 1.14 to 3.03 | ||
Unknown | 5 |